Last reviewed · How we verify

NCT04396743

Comparative Evaluation of Two PRF Formulations on Quality of Life and Healing of Apicomarginal Defects

Status unknown NA Last updated 21 May 2020
What this trial tests

NA trial testing Periapical surgery with use of prf-high clot and membrane in Apico Marginal Defects in 32 participants. Status unknown.

Timeline
11 December 2019
Primary endpoint
11 April 2021
11 April 2021

Quick facts

Lead sponsorPostgraduate Institute of Dental Sciences Rohtak
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment32
Start date11 December 2019
Primary completion11 April 2021
Estimated completion11 April 2021
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

Postgraduate Institute of Dental Sciences Rohtak

Who can join

Adults 16 to 60, any sex, with Apico Marginal Defects. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Healing of apicomarginal defects using 2 different formulations of PRF i.e PRF -high and PRF-medium will be assessed and compared using 2D and 3D criteria. Also, in vitro evaluation of the PRF formulations and quality of life will be compared between the two groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Postgraduate Institute of Dental Sciences Rohtak trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04396743.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing